Fifth Lane Capital’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$5K 497
2022
Q1
$5K Sell
10,000
-31,609
-76% -$23K ﹤0.01% 305
2021
Q4
$40K Buy
+41,609
New +$41.3K 0.02% 197

Other funds holding WPCB.WS

Fifth Lane Capital's WPCB.WS Position: Q2 2022 in Review

Fifth Lane Capital sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q2 2022, closing a stake of 10,000 shares — an estimated $5K sold.

Fifth Lane Capital first reported a position in WPCB.WS in Q4 2021 and held it in 2 quarters. The position peaked at $40K in Q4 2021. 51 funds tracked by Wall St. Rank hold WPCB.WS as of Q2 2022.

  • Fifth Lane Capital reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 10,000 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $5K.
  • Fifth Lane Capital first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
  • Fifth Lane Capital's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $40K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on Fifth Lane Capital's 13F filing for Q2 2022, filed 15 Aug 2022.